Received Jun 16, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | — | SC / OT |
This subcutaneous vaccine formulation was administered as IM. No abnormal S/S to report. This was administration error only. Reported to PCP immediately. Follow up Titers put in place to check if patient received immunity from it.
None reported
HTN, Afib, left ventricular hypertrophy, atrial enlargement, presence of watchman left atrial appendage, CAD, ED, Solitary kidney acquired
Aspirin, plavix, iron, rosuvastatin, tadalafil, B12
NKA
Follow up Titers put in place to check if patient received immunity from it.